AR092169A1 - Composicion farmaceutica sinergica adaptada para ser administrable oralmente como antiparasitario y procesos para prepararla - Google Patents
Composicion farmaceutica sinergica adaptada para ser administrable oralmente como antiparasitario y procesos para prepararlaInfo
- Publication number
- AR092169A1 AR092169A1 ARP130102935A ARP130102935A AR092169A1 AR 092169 A1 AR092169 A1 AR 092169A1 AR P130102935 A ARP130102935 A AR P130102935A AR P130102935 A ARP130102935 A AR P130102935A AR 092169 A1 AR092169 A1 AR 092169A1
- Authority
- AR
- Argentina
- Prior art keywords
- oralally
- antiparasitary
- administrable
- pharmaceutical
- prepare
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Una composición farmacéutica sinérgica para el tratamiento de parasitosis humana de Mebendazol (MBDZ) con Nitazoxanida (NTZX), que amplía significativamente el espectro del MBDZ contra protozoos y refuerza la acción antihelmíntica de la NTZX.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2012/055166 WO2014049397A1 (es) | 2012-09-27 | 2012-09-27 | Composición sinérgica de nitazoxanida y mebendazol, procesos para prepararla y el uso de dicha composición para el tratamiento de la parasitosis humana |
Publications (1)
Publication Number | Publication Date |
---|---|
AR092169A1 true AR092169A1 (es) | 2015-03-25 |
Family
ID=50387067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130102935A AR092169A1 (es) | 2012-09-27 | 2013-08-16 | Composicion farmaceutica sinergica adaptada para ser administrable oralmente como antiparasitario y procesos para prepararla |
Country Status (10)
Country | Link |
---|---|
US (1) | US20150250765A1 (es) |
EP (1) | EP2902024B1 (es) |
AR (1) | AR092169A1 (es) |
BR (1) | BR112015006861B1 (es) |
CL (1) | CL2015000778A1 (es) |
CR (1) | CR20150190A (es) |
MX (1) | MX340272B (es) |
NI (1) | NI201500045A (es) |
UY (1) | UY34967A (es) |
WO (1) | WO2014049397A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2610791B1 (es) * | 2016-12-22 | 2018-02-07 | Elena TEIJEIRA PRIETO | Uso del mebendazol para la eliminación de los gusanos de fuego en acuarios de arrecife |
CN111494327B (zh) * | 2020-06-23 | 2023-09-05 | 瑞阳制药股份有限公司 | 甲苯咪唑咀嚼片的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657267A (en) | 1969-06-20 | 1972-04-18 | Janssen Pharmaceutica Nv | Benzimidazole carbamates |
GB1437800A (en) | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
US5387598A (en) | 1994-04-13 | 1995-02-07 | Rossignol; Jean-Francois | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
US20050171169A1 (en) * | 2004-02-02 | 2005-08-04 | Rossignol Jean F. | Combination chemotherapy for helminth infections |
US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
-
2012
- 2012-09-27 WO PCT/IB2012/055166 patent/WO2014049397A1/es active Application Filing
- 2012-09-27 US US14/431,623 patent/US20150250765A1/en not_active Abandoned
- 2012-09-27 MX MX2015003941A patent/MX340272B/es active IP Right Grant
- 2012-09-27 EP EP12885371.0A patent/EP2902024B1/en active Active
- 2012-09-27 BR BR112015006861-8A patent/BR112015006861B1/pt active IP Right Grant
-
2013
- 2013-08-06 UY UY0001034967A patent/UY34967A/es unknown
- 2013-08-16 AR ARP130102935A patent/AR092169A1/es unknown
-
2015
- 2015-03-26 NI NI201500045A patent/NI201500045A/es unknown
- 2015-03-27 CL CL2015000778A patent/CL2015000778A1/es unknown
- 2015-04-13 CR CR20150190A patent/CR20150190A/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112015006861A2 (pt) | 2017-07-04 |
UY34967A (es) | 2014-04-30 |
US20150250765A1 (en) | 2015-09-10 |
MX2015003941A (es) | 2015-07-21 |
CR20150190A (es) | 2015-07-09 |
WO2014049397A1 (es) | 2014-04-03 |
EP2902024A4 (en) | 2016-06-22 |
EP2902024A1 (en) | 2015-08-05 |
NI201500045A (es) | 2016-02-16 |
MX340272B (es) | 2016-06-30 |
BR112015006861B1 (pt) | 2021-10-13 |
EP2902024B1 (en) | 2017-11-29 |
CL2015000778A1 (es) | 2015-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018000223A1 (es) | Combinación de antagonista de pd-1 con un inhibidor de egfr | |
CL2015002710A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso. | |
CR20150376A (es) | Compuestos sustituidos de pirrolopirimidina, compuestos de los mismos y metodos de tratamiento con los mismos | |
GT201500312A (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2015002145A1 (es) | Preparación, usos y formas sólidas de ácido obeticólico (divisional de solicitud n° 3475-2014) | |
CL2018000222A1 (es) | Nueva combinación para el uso en el tratamiento del cáncer | |
SV2017005489A (es) | Terapias de combinación para el tratamiento de cánceres | |
DOP2015000156A (es) | Derivados de exendina-4 funcionalizada | |
NI201600051A (es) | Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores | |
BR112016014410A2 (pt) | terapia de combinação com vacina de neoantígeno | |
GT201500081A (es) | Derivados de exendina-4 como agonistas duales de glp1/glucagón | |
ES2765949T8 (es) | Terapia que involucra anticuerpos contra la claudina 18.2 para el tratamiento del cáncer | |
CO6821938A2 (es) | Un compuesto de guanidina o una sal del mismo para el tratamiento de enfermedades relacionadas con vap -1 | |
NI201400111A (es) | Tratamiento del cáncer con inhibidores tor cinasa | |
NI201400112A (es) | Tratamiento del cáncer con inhibidores tor cinasa | |
CO6511249A2 (es) | Composiciones que comprenden tramadol y celecoxib en el tratamiento del dolor | |
CL2015001610A1 (es) | Compuestos derivados de pirimido-[4,5-b]-quinolina-4,5(3h,10h)-dionas para utilizarse como un medicamento para el tratamiento de una enfermedad causada por una mutacion sin sentido; composicion y combinacion farmaceutica que los comprende. | |
DOP2016000118A (es) | Tienopirimidinas como inhibidores mknk1 y mknk2 | |
GT201400003A (es) | Una nueva composición terapéutica que contiene apomorfina como principio activo | |
SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
BR112017021190A2 (pt) | composição farmacêutica e o uso da mesma | |
CL2016001130A1 (es) | Composiciones sólidas de triglicéridos y usos de estas | |
ECSP15033898A (es) | Composición antifúngica tópica para el tratamiento de onicomicosis | |
MY181685A (en) | Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer | |
CL2017001773A1 (es) | Análogos de calcitonina para tratar enfermedades y trastornos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |